摘要
采用前药设计原理,以普拉格雷代谢物为先导化合物,设计并合成了一系列2-羟基四氢噻吩并吡啶烷氧羰基酯类衍生物(1~8),结构均经IR、1H NMR、13C NMR、MS和HRMS确证。对目标化合物进行了抗血小板聚集的药理活性评价,活性测试结果显示除化合物5外,其余大部分化合物都显示出较好的抗血小板聚集活性,部分化合物显示了与普拉格雷相当的抗血小板聚集活性。
With the metabolite of prasugrel as a lead compound,a series of 2-hydroxytetrahydrothienopyridine derivatives were designed and synthesized based on prodrug theory.Their structures were confirmed by IR,1 H NMR,13 C NMR,MS,and HRMS.The target compounds 1-8 were biologically evaluated for their antiplatelet aggregation activity.Except for compound 5,most of the test compounds exhibited potent antiplatelet aggregation activity,some exhibiting similar potent activity to prasugrel.The compounds are worthy of further study to search for novel antithrombotic agents with improved potency,safety profile and chemical stability.
出处
《中国药科大学学报》
CAS
CSCD
北大核心
2011年第4期305-309,共5页
Journal of China Pharmaceutical University
关键词
普拉格雷
结构修饰
2-羟基四氢噻吩并吡啶衍生物
合成
抗血小板聚集
prasugrel
structural modification
2-hydroxytetrahydrothienopyridine derivatives
synthesis
anti-platelet aggregation